Clozapine and Second-Generation Antipsychotics for Schizophrenia, with John Kane, MD
Among the challenges hindering the pharmaceutical treatment of schizophrenia may be the very nomenclature used to describe its most viable agents. In the second segment of an interview with HCPLive during the American Psychiatric Association (APA) 2024 …